Inhibikase Therapeutics (IKT) Market Capitalization (2020 - 2026)
Inhibikase Therapeutics (IKT) posted Market Capitalization of $354.38 million for Q2 2026, up 143.9% from $145.31 million a year earlier and up 22.4% from the prior quarter.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Market Capitalization (2020 - 2026) Analysis & Trends
For FY2025, Inhibikase Therapeutics' Market Capitalization came in at $201.54 million, up 161.5% from FY2024.
- Annual Market Capitalization shows a five-year compound annual growth rate of 28.9% (FY2020 to FY2025).
- In prior years, Inhibikase Therapeutics' Market Capitalization was $77.06 million in FY2024 (+880.9%), $7.86 million in FY2023 (-37.7%), $12.61 million in FY2022 (-52.9%) and $26.77 million in FY2021 (-52.8%).
- The Q2 2026 figure stands as the highest quarterly Market Capitalization in data going back to Q4 2020.
- On a year-over-year basis, Market Capitalization has increased in each of the last three quarters, with growth averaging 258.9% over the last five quarters.
- The strongest year-over-year quarter for Market Capitalization in the past five years was Q4 2024, with growth of 880.9%; the weakest was Q3 2023, with a decline of 67.5%.
- According to Business Quant data, Market Capitalization for the three prior quarters was $289.48 million (Q1 2026), $201.54 million (Q4 2025) and $121.19 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Inhibikase Therapeutics | 359.62 Mn | -225.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 354.38 Mn |
| Mar 31, 2026 | 289.48 Mn |
| Dec 31, 2025 | 201.54 Mn |
| Sep 30, 2025 | 121.19 Mn |
| Jun 30, 2025 | 145.31 Mn |
| Mar 31, 2025 | 162.81 Mn |
| Dec 31, 2024 | 77.06 Mn |
| Sep 30, 2024 | 9.70 Mn |
| Jun 30, 2024 | 8.73 Mn |
| Mar 31, 2024 | 13.99 Mn |
| Dec 31, 2023 | 7.86 Mn |
| Sep 30, 2023 | 7.45 Mn |
| Jun 30, 2023 | 19.10 Mn |
| Mar 31, 2023 | 20.45 Mn |
| Dec 31, 2022 | 12.61 Mn |
| Sep 30, 2022 | 22.96 Mn |
| Jun 30, 2022 | 18.75 Mn |
| Mar 31, 2022 | 37.34 Mn |
| Dec 31, 2021 | 26.77 Mn |
| Sep 30, 2021 | 47.80 Mn |
API Access
Inhibikase Therapeutics Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();